Recent Finacing
Recent Raise
Immagina Biotechnology develops and sells RiboLace ribosome profiling tools for research labs and pharmaceutical companies to study cellular function and enable RNA-targeted drug development in cancer and neurodegeneration.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor